Petet Enzinger, MD

DFCIBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS3
- INTERVENTIONS1
- SINCE2008

Perioperative Panitumumab and Epirubicin Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma
April 2008 - April 2011
Adenocarcinoma
Esophageal Diseases
Stomach Neoplasms
Panitumumab, Epirubicin, Oxaliplatin, Xeloda



